Our law firm is currently handling lawsuits on behalf of individuals who have taken Zantac to treat intestinal issues. Zantac has been found to contain a toxic and carcinogenic chemical, known as NDMA, which may increase the risk of certain cancers.
Zantac is classified as a histamine-2 blocker that reduces the production of acid in the stomach. Zantac is prescribed to treat stomach and intestinal ulcers, gastroesophageal reflux disease (GERD), and other conditions which cause heartburn. Zantac is chemically known as ranitidine hydrochloride.
After researchers discovered that ranitidine medications may be contaminated with NDMA, Zantac and other generic counterparts issued voluntary recalls. NDMA has been identified as a probable human carcinogen. In April 2020, the Food and Drug Administration (FDA) ordered the withdrawal of Zantac and other ranitidine medications from the market after determining that levels of the carcinogen increase over time when stored at normal temperatures.
Personal injury lawsuits have been consolidated in the Southern District of Florida. A separate class action suit in California is scheduled for trial in October 2022. To date, there have been no settlements or verdicts against the manufacturers and distributors of Zantac.
Zantac and other ranitidine-containing medications could be contaminated with a carcinogen that increases the risk of cancer. Ranitidine may cause breast cancer, stomach cancer, bladder cancer, intestinal cancer, colorectal cancer, prostate cancer, pancreatic cancer, leukemia, non-Hodgkin’s lymphoma, and multiple myeloma.
If you or a loved one has been injured by Zantac, you may recover compensation for any or all of the following:
The Lake Law Firm was founded by Edward J. Lake, Esq., a personal injury lawyer for over 25 years. Our dedicated team of attorneys is committed to seeking justice on behalf of those who have suffered injury or death due to the negligence of others. Our experienced attorneys handle many different types of pharmaceutical drugs, medical devices, and other defective products. The lawyers in our firm have helped collect millions of dollars for their clients. The Lake Law Firm will advocate for you and your rights. Please contact us for a free confidential case evaluation at (888) 274-0139 or submit an inquiry on this page.
In September 2019, the Food and Drug Administration (FDA) began investigating reports that NDMA was detected in Zantac. The carcinogen was found at various levels in the samples of Zantac that were tested. An independent lab in California, Emery Pharma, found that heat and time contribute to higher levels of NDMA in Zantac. This means that it is possible for levels of NDMA to increase after the medication is packaged and stored. The FDA did not issue a recall at that time.
On April 1, 2020, the FDA issued an alert to manufacturers requesting the removal of all prescription and over-the-counter ranitidine drugs from the market. The FDA confirmed that NDMA levels in ranitidine increased not just under higher temperatures, but also under normal circumstances. The levels of NDMA increased significantly at higher temperatures and were also exacerbated in products that were older.